Disease activity score-28 values differ considerably depending on patient's pain perception and sex

Journal of Rheumatology

Volumn 34, Issue 12, 2007, Pages 2382-2387

  Leeb, Burkhard F ^a,b   Haindl, Pia M ^a   Maktari, Adil ^a   Nothnagl, Thomas ^a   Rintelen, Bernhard ^a  

^a Stockerau Hospital   (Austria)

^b Lower Austrian Center for Rheumatology   (Austria)

Author keywords

Disease activity assessment; Gender; Pain; Rheumatoid arthritis

Indexed keywords

ADALIMUMAB; ANTIMALARIAL AGENT; C REACTIVE PROTEIN; CYCLOSPORIN A; ETANERCEPT; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; OM 89; PREDNISOLONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT TOOL; CONFOUNDING VARIABLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE ACTIVITY ACTIVITY SCORE 28; DISEASE DURATION; FEMALE; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NOCICEPTION; PAIN ASSESSMENT; PHYSICIAN; PRIORITY JOURNAL; REGRESSION ANALYSIS; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; STUDENT T TEST; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PAIN THRESHOLD; RHEUMATOID FACTOR; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 36849083659     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. van der Heijde DM, van 't Hof M, van Riel PL, van de Putte LB. Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol 1993;20:579-81.
2. Prevoo ML, van 't Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
3. Leeb BF, Andel I, Sautner J, et al. Disease activity measurement of rheumatoid arthritis. Comparison of the SDAI and the DAS28 in daily routine. Arthritis Rheum 2005;53:56-61.
4. Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 2005;52:3381-90.
5. Aletaha D, Ward MM. Duration of rheumatoid arthritis influences the degree of functional improvement in clinical trials. Ann Rheum Dis 2006;65:227-33.
6. Barsky AJ, Peekna HM, Borus JF. Somatic symptom reporting in women and men. J Gen Intern Med 2001;16:266-75.
7. Leeb BF, Andel I, Sautner J, Nothnagl T, Rintelen B. The DAS28 in rheumatoid arthritis and fibromyalgia patients. Rheumatology Oxford 2004;43:1504-7.
8. Leeb BF, Andel I, Leder S, Leeb BA, Rintelen B. The patient's perspective and disease activity indexes. Rheumatology Oxford 2005;44:360-5.
9. Koopmann WJ. Prospects for autoimmune disease: Research advances in rheumatoid arthritis. JAMA 2001;285:648-50.
10. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
11. Young A, Koduri G, Batley M, et al. Early Rheumatoid Arthritis Study (ERAS) group. Mortality in rheumatoid arthritis: Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology Oxford 2007;46:350-7. Epub 2006 Aug 14.
12. Callahan LF, Cordray DS, Wells G, Pincus T. Formal education and five-year mortality in rheumatoid arthritis: mediation by helplessness scale score. Arthritis Care Res 1996;9:463-72.
13. Genovese MC, Bathon JM, Martin RW, et al. Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes. Arthritis Rheum 2002;46:1443-50.
14. Breedveld FC, Weisman MH, Kavanaugh AF, et al. The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum 2006;54:26-37.
15. Glasnovic M, Bosnjak I, Vcev A, et al. Anti-citrullinated antibodies, radiological joint damages and their correlations with Disease Activity Score (DAS28). Coll Antropol 2007;31:345-8.
16. van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Toes RE, Huizinga TW. Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther 2005;7:R949-58. Epub 2005 Jun 14.
17. Ates A, Kinikli G, Turgay M, Akay G, Tokgöz G. Effects of rheumatoid factor isotypes on disease activity and severity in patients with rheumatoid arthritis: a comparative study. Clin Rheumatol 2007;26:538-45. Epub 2006 Jun 28.
18. Ward MM. Clinical measures in rheumatoid arthritis: which are most useful in assessing patients? J Rheumatol 1994;21:17-27.
19. Wolfe F, Michaud K, Pincus T. A composite disease activity scale for clinical practice, observational studies, and clinical trials: the Patient Activity Scale (PAS/PAS-II). J Rheumatol 2005;32:2410-5.
20. Harrison MJ, Tricker KJ, Davies L, et al. The relationship between social deprivation, disease outcome measures, and response to treatment in patients with stable, long-standing rheumatoid arthritis. J Rheumatol 2005;32:2330-6.
21. Castagnetta L, Granata OM, Traina A, et al. Role for sex steroids in autoimmune diseases: a working hypothesis and supporting data. Ann NY Acad Sci 2002;966:193-203.
22. Krishnan E, Sokka T, Hannonen P. Smoking-gender interaction and risk for rheumatoid arthritis. Arthritis Res Ther 2003;5:R158-62. Epub 2003 Mar 24.
23. Wolfe F, Michaud K. The clinical and research significance of the erythrocyte sedimentation rate. J Rheumatol 1994;21:1227-37.
24. Theis KA, Helmick CG, Hootman JM. Arthritis burden and impact are greater among U.S. women than men: intervention opportunities. J Womens Health Larchmt 2007;16:441-53.
25. Affleck G, Tennen H, Keefe FJ, et al. Everyday life with osteoarthritis or rheumatoid arthritis: independent effects of disease and gender on daily pain, mood, and coping. Pain 1999;83:601-9.
26. Sokka T, Kautiainen H, Hannonen P, Pincus T. Changes in Health Assessment Questionnaire disability scores over five years in patients with rheumatoid arthritis compared with the general population. Arthritis Rheum 2006;54:3113-8.
27. Kirwan JR. Conceptual issues in scoring radiographic progression in rheumatoid arthritis. J Rheumatol 1999;26:720-5.
28. de Vries-Bouwstra J, Le Cessie Allaart C, Breedveld F, Huizinga T. Using predicted disease outcome to provide differentiated treatment of early rheumatoid arthritis. J Rheumatol 2006;33:1747-53.
29. Hakkinen A, Kautiainen H, Hannonen P, Ylinen J, Arkela-Kautiainen M, Sokka T. Pain and joint mobility explain individual subdimensions of the Health Assessment Questionnaire (HAQ) disability index in patients with rheumatoid arthritis. Ann Rheum Dis 2005;64:59-63. Epub 2004 May 6.
30. Pincus T. The American College of Rheumatology (ACR) Core Data Set and derivative "patient only" indices to assess rheumatoid arthritis. Clin Exp Rheumatol 2005;23 Suppl 39:S109-13.
31. Leeb BF, Bird HA. A disease activity score for polymyalgia rheumatica (PMR-AS). Ann Rheum Dis 2004;63:1279-83.
32. Grigor C, Capell H, Stirling A, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004;364:263-9.
33. Leeb BF, Sautner J, Leeb BA, Fassl C, Rintelen B. Lack of agreement between the patient's and physician's perception of rheumatoid arthritis' disease activity changes. Scand J Rheumatol 2006;35:441-6.
34. Kane RL, Bershadsky B, Rockwood T, Saleh K, Islam NC. Visual analog scale pain reporting was standardized. J Clin Epidemiol 2005;58:618-23.
35. Taal E, Rasker JJ, Seydel ER, Wiegman O. Health status, adherence with health recommendations, self efficacy and social support in patients with rheumatoid arthritis. Patient Educ Couns 1993;20:63-76.
36. Callahan LF, Smith WJ, Pincus T. Self-report questionnaires in five rheumatic diseases: comparisons of health status constructs and associations with formal education level. Arthritis Care Res 1989;2:122-31.
37. Harth M, Pope J. The measure of our measures. Rheumatology Oxford 2004;43:1465-7.